British Pharmacopoeia new best practice guidance on ATMP Flow Cytometry and Vector Copy Number (Cell and Gene Therapy Catapult – Regulatory Round-up – Juin 2022)
The Advanced Therapy Medicinal Products (ATMP) Flow Cytometry and Vector Copy Number best practice guidance offers a practical and phase-appropriate validation tool to help cell and gene therapy programmes to succeed. This guidance document is available as part of the BP online and is now free to download.
See all of Catapult’s Regulatory Round-up for June 2022 here. Published on the 1st of July 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (27 octobre 2022). British Pharmacopoeia new best practice guidance on ATMP Flow Cytometry and Vector Copy Number (Cell and Gene Therapy Catapult – Regulatory Round-up – Juin 2022). ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/o640





